Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Nature Reviews. Cancer|April 25, 2006
Is there more to BARD1 than BRCA1?Irmgard Irminger-Finger, Charles Edward JeffordThe International Journal of Biochemistry & Cell Biology|May 24, 2008
Preeclampsia: a danger growing in disguiseIrmgard Irminger-Finger, Nicole Jastrow, Olivier IrionThe International Journal of Biochemistry & Cell Biology|January 8, 2016
New concepts on BARD1: Regulator of BRCA pathways and beyondIrmgard Irminger-Finger, Magda Ratajska, Maxim PilyuginCancer Letters|August 2, 2016
BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatinKamila A Marzec, Estefania Martino-Echarri, Irmgard Irminger-Finger, et al.Genes|July 2, 2021
BARD1 Autoantibody Blood Test for Early Detection of Ovarian CancerMaxim Pilyugin, Magdalena Ratajska, Maciej Stukan, et al.Oncogene|April 13, 2004
Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activityCharles Edward Jefford, Anis Feki, Jean Harb, et al.Journal of Neuroimmunology|December 4, 2003
Chemokine-induced cell death in CCR5-expressing neuroblastoma cellsLaetitia Cartier, Michel Dubois-Dauphin, Oliver Hartley, et al.Oncology Reports|May 11, 2006
BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing ratsIrmgard Irminger-Finger, Sílvia Busquets, Fabrice Calabrio, et al.The International Journal of Biochemistry & Cell Biology|June 9, 2007
Identification of BARD1 splice-isoforms involved in human trophoblast invasionLin Li, Marie Cohen, Jianyu Wu, et al.Oncogene|March 23, 2005
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinaseAnis Feki, Charles Edward Jefford, Philip Berardi, et al.Pageof 4